Plexium scores $35m
Plexium Inc, a developer of protein degrading therapeutics directed towards historically challenging drug targets, has secured $35 million in financing.
21 January 2021•1 min read
Plexium Inc, a developer of protein degrading therapeutics directed towards historically challenging drug targets, has secured $35 million in financing.
